Exploring Undervalued Small Caps With Insider Actions In June 2024

In This Article:

As global markets exhibit a mix of cautious optimism and selective growth, with the S&P 500 reaching new highs and modest gains across major indices, investors are keenly observing market dynamics. In this environment, undervalued small-cap stocks, particularly those with insider buying actions, could present intriguing opportunities for discerning investors looking to potentially capitalize on overlooked value in the current economic landscape.

Top 10 Undervalued Small Caps With Insider Buying

Name

PE

PS

Discount to Fair Value

Value Rating

Tokmanni Group Oyj

16.6x

0.5x

39.37%

★★★★★★

Cabka

NA

0.5x

22.13%

★★★★★★

Columbus McKinnon

21.4x

1.0x

42.13%

★★★★★☆

PCB Bancorp

8.6x

2.3x

46.54%

★★★★★☆

THG

NA

0.4x

33.18%

★★★★★☆

Norconsult

28.3x

1.0x

41.59%

★★★☆☆☆

Robert Walters

20.6x

0.3x

35.50%

★★★☆☆☆

Kambi Group

17.9x

1.5x

23.86%

★★★☆☆☆

Papa John's International

20.7x

0.7x

31.02%

★★★☆☆☆

Community West Bancshares

18.7x

2.9x

42.25%

★★★☆☆☆

Click here to see the full list of 233 stocks from our Undervalued Small Caps With Insider Buying screener.

Let's take a closer look at a couple of our picks from the screened companies.

Clarity Pharmaceuticals

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Clarity Pharmaceuticals is a company focused on the development of radiopharmaceuticals, with a market capitalization of approximately A$9.49 million.

Operations: Radiopharmaceutical Development generates revenue of A$9.49 million, with a consistent gross profit margin of 100%. However, the company faces challenges as operating expenses have escalated to A$42.21 million, significantly impacting net income which stands at -A$30.56 million.

PE: -51.7x

Clarity Pharmaceuticals, engaged in critical industry conferences, recently showcased at events such as the ASCO Annual Meeting and SNMMI 2024, highlighting its active role in the medical community. Despite its current unprofitability with no short-term change expected, insider confidence is evident; they recently purchased shares, signaling belief in long-term prospects. This aligns with a recent follow-on equity offering raising A$20 million at a slight discount—further evidence of strategic capital management despite past shareholder dilution.

ASX:CU6 Share price vs Value as at Jun 2024
ASX:CU6 Share price vs Value as at Jun 2024

Kinetic Development Group

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Kinetic Development Group is a company primarily engaged in the property development sector with a market capitalization of approximately CN¥1.23 billion.